Stem cell technology and computational modelling offer the promise of reducing the current burden of cardiotoxicity assessment.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A high-throughput in vitro ring assay for vasoactivity using magnetic 3D bioprinting
Scientific Reports Open Access 01 August 2016
-
Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications
Scientific Reports Open Access 09 March 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
PowerPoint slides
Rights and permissions
About this article
Cite this article
Chi, K. Revolution dawning in cardiotoxicity testing. Nat Rev Drug Discov 12, 565–567 (2013). https://doi.org/10.1038/nrd4083
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4083
This article is cited by
-
Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies
Current Hematologic Malignancy Reports (2017)
-
Evolution of strategies to improve preclinical cardiac safety testing
Nature Reviews Drug Discovery (2016)
-
A high-throughput in vitro ring assay for vasoactivity using magnetic 3D bioprinting
Scientific Reports (2016)
-
Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications
Scientific Reports (2015)
-
Assessing the Arrhythmogenic Potential of New Drugs: A Guide for the Pharmaceutical Physician
Pharmaceutical Medicine (2015)